{
    "2021-08-23": [
        [
            {
                "time": "",
                "original_text": "机构买入评级大幅扩围，64股看涨逾70%",
                "features": {
                    "keywords": [
                        "机构买入",
                        "评级",
                        "扩围",
                        "看涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：头部CRO纷纷布局DEL 关注进度领先企业",
                "features": {
                    "keywords": [
                        "医药行业",
                        "CRO",
                        "DEL",
                        "进度领先企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "六券商周二看好六大板块",
                "features": {
                    "keywords": [
                        "券商",
                        "看好",
                        "板块"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "多行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：药明康德、迈瑞医疗等市值底部已现 无需恐慌",
                "features": {
                    "keywords": [
                        "医药生物",
                        "药明康德",
                        "迈瑞医疗",
                        "市值底部"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "海通证券：予药明康德(603259.SH)“优于大市”评级 价值区间180-187.5元",
                "features": {
                    "keywords": [
                        "海通证券",
                        "药明康德",
                        "优于大市",
                        "价值区间"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "极致赋能 | 药明康德首届投资者开放日成功举行",
                "features": {
                    "keywords": [
                        "药明康德",
                        "投资者开放日",
                        "成功举行"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "海通证券研究所早报",
                "features": {
                    "keywords": [
                        "海通证券",
                        "研究所",
                        "早报"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "融资客青睐4股，江苏舜天买入占比高达41%",
                "features": {
                    "keywords": [
                        "融资客",
                        "青睐",
                        "江苏舜天",
                        "买入占比"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "个股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}